产品编号：D471417
产品规格：2.5mg
产品价格：面议
| 标准品编号: | D471417 |
| 名称: | 6,6-Dimethyl-5,7-dioxaspiro[2.5]octan-4,8-dione-d4 |
| 别名: | 1,1-Cyclopropanedicarboxylic Acid Cyclic Isopropylidene Ester-d4; 1,1-Cyclopropanedicarboxylic Acid Cyclic 1-Methylethylidene Ester-d4; 2,2-Propanediol Cyclic 1,1-Cyclopropanedicarboxylate-d4; 6,6-Dimethyl-5,7-dioxaspiro[2.5]octane-4,8-dione-d4 |
| 参考CAS号: | 类似: 5617-70-9 |
| 分子式: | C₈H₆D₄O₄ |
| 外观: | Beige Solid |
| 分子量: | 174.19 |
| 储存: | -20°C Freezer |
| 溶解性: | Acetone, Alcohols, Dichloromethane |
| 种类: | Building Blocks; Isotopic Labeled Analogues; |
| 应用: | 6,6-Dimethyl-5,7-dioxaspiro[2.5]octan-4,8-dione-d4 is a labelled analogue of 6,6-Dimethyl-5,7-dioxaspiro[2.5]octan-4,8-dione (D471415), which is used as a reagent to synthesize Bis-benzimidazoles, compounds that act as inhibitors of Type II Dihydrofolate reductase (an enzyme that is produced by bacteria in response to Trimethoprim [T795615]as a defense mechanism). 6,6-Dimethyl-5,7-dioxaspiro[2.5]octan-4,8-dione-d4 is also an intermediate in synthesizing 2-(Hydroxymethyl)butanoic-d5 Acid (H946457), which is used as a substrate to study the activity of 2-methyl-3hydroxybutyryl-CoA dehydrogenase deficiency in patients and carriers. |
| 参考文献 | |
